ONCTERNAL THERAPEUTICS INC - COM (ONCT)

CUSIP: 68236P107

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / COM
Total 13F shares
8,387,387
Share change
-941,691
Total reported value
$4,495,852
Price per share
$0.54
Number of holders
36
Value change
-$112,906
Number of buys
8
Number of sells
24

Quarterly Holders Quick Answers

What is CUSIP 68236P107?
CUSIP 68236P107 identifies ONCT - ONCTERNAL THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ONCTERNAL THERAPEUTICS INC - COM (ONCT) as of Q4 2023

As of 31 Dec 2023, ONCTERNAL THERAPEUTICS INC - COM (ONCT) was held by 36 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,387,387 shares. The largest 10 holders included VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, BlackRock Inc., Pasadena Private Wealth, LLC, Richmond Brothers, Inc., RENAISSANCE TECHNOLOGIES LLC, LPL Financial LLC, STATE STREET CORP, IEQ CAPITAL, LLC, and MORGAN STANLEY. This page lists 36 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.